Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Equity Stake

19 Jun 2007 11:44

Quadrise Fuels International PLC19 June 2007 19th June 2007 AIM: QFI Quadrise Fuels International plc ("Quadrise" or "the Company") Quadrise Canada Corporation acquires equity stake in Clean Energy Systems Inc Quadrise Canada Corporation ("QCC"), and Paxton Corporation ("Paxton") havejointly entered into an agreement with Clean Energy Systems Inc ("CES") ofSacramento, USA. The agreement is for an aggregate equity position in CES, afterexercise of all rights and warrants of approximately 18% on a fully dilutedbasis. Quadrise Fuels International ("QFI"), the AIM listed specialistmanufacturer of MSAR(R) emulsion fuel has a 20% equity stake in QCC and an 8%equity stake in Paxton. In exchange for this position, Paxton and QCC will provide funds for developmentof the CES power generation system. The development programme will focus ondesigning and manufacturing a 12" gas generator capable of producing 65MW ofelectrical power. CES have numerous patents and filed additional patent applications that form thebasis for the first Zero Emission Power Plant (ZEPPTM) in the USA. The CESsystem envisages oxy-firing of a wide range of fuels including the Quadriseproduct, MSAR(R). Oxy-firing permits capture of the combustion product, carbondioxide (the greenhouse gas) in a concentrated form. The high concentrationcarbon dioxide produced in this manner is of a quality suitable for injectioninto hydrocarbon reservoirs to enhance oil recovery and is of considerable valueto the petroleum industry Bill Howe, Chief Executive of Quadrise Fuels International, commented: "Carbondioxide is in short supply in North America. The CES technology offers theopportunity of co-production of saleable power and by-product carbon dioxidefrom in situ oil, together with enhanced oil recovery and simultaneouselimination of greenhouse gas emissions. For QFI, the development of a powergeneration system that was tested using MSAR(R), and has so many 'value add'features is a fundamental progression for the company." Running concurrently with the generator development programme, Paxton is workingwith CES to develop a commercial scale 65MW zero emission MSAR(R) fuelled powerplant in California. For further information, please contact: Quadrise Fuels International plcBill Howe, CEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov / Siobhan Sergeant+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson / Clare Irvine+44 (0)20 7851 7480 Notes to editors: Quadrise Fuels International plc ("Quadrise") produces an emulsion fuel as a lowcost substitute for conventional heavy fuel oil ("HFO") for use in powergeneration plants and large steam raising or energy consuming industries. In manufacturing its fuels, Quadrise uses the least valuable elements of the oilbarrel, thus providing a very cost effective product whilst simultaneouslyfacilitating a means to market for the least desirable heavy crudes and refineryderived residues. The emulsion fuel product, termed MSAR(R) (Multiphase Superfine AtomisedResidue), has superior combustion characteristics to conventional HFO and coal,and has comparable or superior environmental performance in respect ofgreenhouse emissions. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSUpdate on active programmes
24th Feb 20147:00 amRNSRoyalty Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.